A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial

BACKGROUND: Thrombolysis with intravenous rt-PA is currently the only approved acute therapy for ischemic stroke. Re-occlusion after initial recanalization occurs in up to 34% in patients treated with rt-PA, probably caused by platelet activation. In acute myocardial infarction, the combination of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zinkstok, SM, Vermeulen, M, Stam, J, de Haan, RJ, Roos, YB
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886039/
https://www.ncbi.nlm.nih.gov/pubmed/20459856
http://dx.doi.org/10.1186/1745-6215-11-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886039/
https://www.ncbi.nlm.nih.gov/pubmed/20459856
http://dx.doi.org/10.1186/1745-6215-11-51

Ejemplares similares